Capillary Technologies India Ltd

Capillary Technologies India Ltd announced its participation in the Small-Cap Investor Conference hosted by Avendus Spark on Monday, June 15, 2026, in Mumbai. The company representatives will engage with investors at this physical event. Capillary Technologies has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during the conference. The company will also update its website with this announcement.

Capillary Technologies India Ltd. announced that its Board of Directors has approved holding the 14th Annual General Meeting (AGM) on Friday, August 28, 2026. The cut-off date for determining shareholders' eligibility to attend the AGM is set as Friday, August 21, 2026. The board meeting commenced at 12:45 P.M. (IST) and concluded at 01:15 P.M. (IST).

Mr. Ravi Jaswani, Head - Finance and Senior Management Personnel (SMP) of Capillary Technologies India Ltd, has resigned to pursue new opportunities. His last working day is June 05, 2026. The company has disclosed this information as per Regulation 30 of the SEBI Listing Regulations.

Capillary Technologies India Ltd submitted a Monitoring Agency Report by CRISIL Ratings Limited for the quarter ended March 31, 2026, regarding the utilization of IPO proceeds, as per SEBI regulations. The report, reviewed by the Audit Committee on May 06, 2026, indicates no deviations from the IPO's stated objectives. The IPO issue size was ₹3,450.00 million, with net proceeds of ₹3,229.08 million after issue expenses of ₹220.92 million.

Capillary Technologies India Ltd announced its financial results for Q4 and FY2026, reporting a 26% YoY revenue growth for Q4 and 23% for the full year. Adjusted EBITDA grew by 28% for Q4 and 43% for FY26. Normalized Profit after tax for FY26 grew by 128%. The company highlighted growth driven by existing customer expansion, new contract value, and the integration of Kognitiv business. The acquisition of SessionM from Mastercard is expected to further strengthen its market position.

Capillary Technologies India Ltd reappointed M/s. Protiviti India Member Private Limited as their Internal Auditors for the Financial Year 2026-27. This decision was made during the Board of Directors meeting held on May 06, 2026, where the board also approved the audited financial results for the quarter and financial year ended March 31, 2026. The auditor's report was issued by M/s. Walker Chandiok & Co. LLP with an unmodified opinion. The trading window, which was closed from April 01, 2026, will re-open after 48 hours from the declaration of the financial results.

Capillary Technologies India Ltd's board approved audited standalone and consolidated financial results for the year ended March 31, 2026, with an unmodified opinion from auditor M/s. Walker Chandiok & Co. LLP. M/s. Protiviti India Member Private Limited was appointed as the Internal Auditors for FY 2026-27. The trading window, closed since April 1, 2026, will re-open 48 hours after the financial results are declared. The board meeting was held on May 06, 2026, from 10:00 AM to 12:00 PM (IST).

Capillary Technologies India Ltd's board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Walker Chandiok & Co. LLP issued an unmodified opinion on the results. Protiviti India Member Private Limited was appointed as the Internal Auditors for FY 2026-27. Trading window closure, initially announced on March 26, 2026, remains in effect and will reopen 48 hours after the financial results are declared.

Capillary Technologies India Ltd. has completed the acquisition of Session M Inc. and its subsidiary Session M Czech Republic s.r.o. on May 1, 2026. This follows the company's initial disclosure on February 24, 2026, regarding the investment in its Wholly Owned Subsidiary, Capillary Pte. Ltd., for the acquisition of 100% shareholding in Session M Inc., a wholly owned subsidiary of Mastercard Inc.

Capillary Technologies India Ltd has announced that its Board of Directors will convene on Wednesday, May 06, 2026. The main agenda for this meeting is to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the trading window for dealing in the company's securities, which closed on April 01, 2026, will remain shut and will re-open 48 hours after the declaration of these financial results.